US Stock Futures Edge Lower Ahead Of Existing-Home Sales Data

Loading...
Loading...
Pre-open movers
US stock futures traded slightly lower in early pre-market trade. The Chicago Fed National Activity Index for February will be released at 8:30 a.m. ET, while existing home sales data for February will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average dropped 9.50 points to 18,023.50, while the Standard & Poor's 500 index futures fell 1.30 points to 2,097.95. Futures for the Nasdaq 100 index slipped 2.55 points to 4,444.70.
A Peek Into Global Markets
European markets were mostly lower today, with the Spanish Ibex Index dropping 0.10%, STOXX Europe 600 Index falling 0.93% and German DAX 30 index dropping 1.38%. French CAC 40 Index slipped 0.96% and London's FTSE 100 Index rose 0.60%. In Asian markets, Japan's Nikkei Stock Average climbed 0.99%, Hong Kong's Hang Seng Index rose 0.49%, China's Shanghai Composite Index gained 1.95% and India's BSE Sensex slipped 0.24%.
Broker Recommendation
Analysts at RBC Capital downgraded
Perrigo CompanyPRGO
from Outperform to Sector Perform and lowered the price target from $175.00 to $170.00. Perrigo shares fell 1.26% to $170.70 in pre-market trading.
Breaking news
  • Cipher Pharmaceuticals CPHR today announced it has licensed the Canadian distribution rights to CF101, a novel chemical entity being developed by Can-Fite Biopharma CANFfor moderate to severe plaque psoriasis and rheumatoid arthritis. To read the full news, click here.
  • ClubCorp MYCC today announced agreements have been signed to acquire a multi-club portfolio of six golf clubs for a combined purchase price of just under $44 million. To read the full news, click here.
  • Isis Pharmaceuticals ISIS announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. To read the full news, click here.
  • GenVec GNVC today announced that it has formed a collaboration with TheraBiologics to develop cancer therapeutics leveraging both GenVec's proprietary gene delivery platform and TheraBiologics' proprietary neural stem cell (NSC) technology. To read the full news, click here.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsEurozoneFuturesGlobalPre-Market OutlookMarketsRBC CapitalUS Stock Futures
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...